STEVEN HARKER: Open Payments
NPI 1568994531 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,149 in 84 payments from 15 companies in 2025. Trend: 2023 $3,617 · 2024 $2,816 · 2025 $3,149
Food & beverage: $2,640Consulting: $475Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $996 |
| Verona Pharma, Inc. | 12 | $823 |
| GENZYME CORPORATION | 4 | $329 |
| GlaxoSmithKline, LLC. | 13 | $224 |
| Electromed, Inc. | 9 | $190 |
| Gilead Sciences, Inc. | 1 | $130 |
| Exact Sciences Corporation | 1 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Amgen Inc. | 2 | $55 |
Products named: Ohtuvayre, BREZTRI, DUPIXENT, AIRSUPRA, SMARTVEST, FASENRA, Epclusa, NUCALA.
Industry payments across NV — which companies pay providers there.
